AIPAC - "Spotlight poster". Sat 12 December 7.15am AEST (Ahjay - have a sleep-in before daily report!!).
PD14-08 Primary efficacy results from AIPAC: A double-blinded, placebo controlled, randomized multinational phase IIb trial comparing weekly paclitaxel plus eftilagimod alpha (soluble LAG-3 protein) vs. weekly paclitaxel plus placebo in HR-positive metastatic breast cancer patients.
Wildiers H, Armstrong A, Cuypere E, Dalenc F, Dirix L, Chan S, Marme F, Schröder CP, Huober J, Wagemans J, Vuylsteke P, Jacquin J-P, Brain E, Kümmel S, Pápai Z, Perjesi L, Mueller C, Brignone C, Triebel F.
Department of General Medical Oncology and Multidisciplinary Breast Centre, Leuven, Belgium;
The Christie NHS Foundation Trust, Manchester, United Kingdom; AZ Sint-Jan Burgge-Oostende AV, Ruddershove, Belgium;
Institut Claudius Regaud, Toulouse, France; GZA ziekenhuizen campus Sint-Augustinus, Oosterveldlaan, Belgium;
Nottingham Cancer Clinical Trials Team (NCCTT), Nottingham, United Kingdom;
National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany;
University Medical Center Groningen, Groningen, Netherlands;
Universitätsfrauenklinik Ulm, Ulm, Germany; AZ Sint-Maarten, Mechelen, Belgium;
CHU UCL Namur, St Elisabeth, Belgium;
Institut de Cancérologie de la Loire (ICO) Lucien Neuwirth, Saint Priest en Jarez, France;
Institut Curie - Hôpital René Huguenin, Saint-Cloud, France;
KEM | Evang. Kliniken Essen-Mitte, Essen, Germany;
MH Egészségügyi Központ Onkológiai Osztály, Budapest, Hungary;
Immutep, Budapest, Hungary; Clinical Development,
Immutep, Berlin, Germany; Research & Development, Immutep, Paris, France.
- Forums
- ASX - By Stock
- IMM
- LAG-3
LAG-3, page-3
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
40.0¢ |
Change
-0.005(1.23%) |
Mkt cap ! $581.0M |
Open | High | Low | Value | Volume |
41.0¢ | 41.5¢ | 39.5¢ | $1.576M | 3.906M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2506 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 8079 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2506 | 0.395 |
4 | 117184 | 0.390 |
5 | 88248 | 0.385 |
8 | 91570 | 0.380 |
1 | 100000 | 0.370 |
Price($) | Vol. | No. |
---|---|---|
0.400 | 8079 | 1 |
0.405 | 30077 | 3 |
0.410 | 97079 | 4 |
0.415 | 323572 | 11 |
0.420 | 560003 | 11 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online